feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Cannabis: Hype vs. Health Reality

Cannabis: Hype vs. Health Reality

12 Dec, 2025

•

Summary

  • Medical cannabis research often shows weak or inconclusive evidence.
  • Nearly 30% of medical cannabis patients show signs of disorder.
  • Doctors lack confidence and knowledge regarding medical cannabis.
Cannabis: Hype vs. Health Reality

A comprehensive review of 15 years of research reveals a significant disconnect between the public's reasons for using cannabis and the scientific evidence supporting its benefits. Millions of Americans turn to cannabis for pain, anxiety, and sleep issues, yet studies indicate the evidence for effectiveness is frequently weak or inconclusive.

The analysis also highlighted that almost 30 percent of individuals using medical cannabis meet the criteria for cannabis use disorder. Compounding this, a notable number of clinicians express uncertainty and a need for further education regarding medical cannabis, indicating a knowledge gap within the medical community.

Despite the growing $32 billion cannabis industry and increasing public acceptance, researchers emphasize the need for rigorous clinical trials. Concerns remain about product quality control, potential contamination, and the risk of adverse effects, particularly for conditions like chronic pain and anxiety where evidence is still developing.

trending

Microsoft AI chief warns safety

trending

DRDO tests scramjet engine

trending

Reliance Jio IPO in 2026

trending

Morgan Stanley RWAs and blockchain

trending

Lecce vs Parma Serie A

trending

Kuldeep Yadav nears ODI record

trending

India vs New Zealand scorecard

trending

Siraj gets batting tips

trending

India vs New Zealand ODI

trending

Booyah Premier League 2026

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The JAMA review found weak or inconclusive evidence for most health reasons people use medical cannabis and noted nearly 30% of patients develop use disorder.
No, a 2021 review cited found only 33% of clinicians globally were confident in their knowledge of medical cannabis, needing more education.
Risks include potential contamination, exposure to toxins if inhaled, and exacerbation of mental health issues, alongside a high rate of cannabis use disorder.

Read more news on

Healthside-arrow

You may also like

Teen Substance Use Hits Historic Lows, Except for Energy Drinks

17 Dec, 2025 • 103 reads

article image

One Week of Excess: How Alcohol Rewired My Brain

17 Dec, 2025 • 124 reads

article image

Psychedelics Outshine Cannabis for OCD Relief

13 Dec, 2025 • 125 reads

article image

Depression Doubles Epilepsy Risk

8 Dec, 2025 • 148 reads

'Scromiting': Marijuana's Disturbing New Symptom

9 Dec, 2025 • 120 reads

article image